Your research cart is empty.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
High-purity, structurally verified peptide sequences for advanced laboratory and pre-clinical applications.
CJC-1295 without DAC (Drug Affinity Complex), also known as Modified GRF (1-29), is a synthetic analog of growth hormone-releasing hormone (GHRH). With the molecular formula C₁₅₂H₂₅₂N₄₄O₄₂ and a molec...
Lab Verified
Clinical Grade
PMID Cited
Published preclinical research has characterized the following molecular pathways and receptor interactions for CJC no DAC.
CJC-1295 NO DAC binds to GHRH receptors on pituitary somatotrophs, activating adenylate cyclase and increasing intracellular cAMP in cell culture.
The peptide triggers intracellular calcium release and growth hormone secretion through GHRH receptor activation.
Preclinical studies have characterized the molecular properties and receptor binding profiles of CJC no DAC in standardized assay systems.
Structure-activity relationship studies have examined the functional domains and binding characteristics of CJC no DAC in cell-free and cell-based systems.
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
GH SecretagoguesBlend · Mixed
For in vitro research use only. Not for human consumption.
GH SecretagoguesC228H388N86O64 · 5358.06 g/mol
For in vitro research use only. Not for human consumption.
GH SecretagoguesC38H49N9O5 · 711.87 g/mol
For in vitro research use only. Not for human consumption.